Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-fourmonth phase III randomized radiographic study.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F14%3A%230003052" target="_blank" >RIV/00023728:_____/14:#0003052 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1002/art.37816" target="_blank" >http://dx.doi.org/10.1002/art.37816</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/art.37816" target="_blank" >10.1002/art.37816</a>
Alternative languages
Result language
angličtina
Original language name
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-fourmonth phase III randomized radiographic study.
Original language description
Objective The purpose of this 24-month phase III study was to examine structural preservation with tofacitinib in patients with rheumatoid arthritis (RA) with an inadequate response to methotrexate (MTX). Data from a planned 12-month interim analysis arereported
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FE - Other fields of internal medicine
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
ARTHRITIS AND RHEUMATISM 2013, Volume: 65 Issue: 3 Pages: 559-570
ISSN
0004-3591
e-ISSN
—
Volume of the periodical
65
Issue of the periodical within the volume
3
Country of publishing house
US - UNITED STATES
Number of pages
12
Pages from-to
559-57
UT code for WoS article
000315452400004
EID of the result in the Scopus database
—